Skip to content

Timing of Rocuronium After Induction With Propofol on Temporal Summation of Pain

The Impact of the Timing of Rocuronium After Induction With Propofol on Temporal Summation of Pain in Gynecologic Laparoscopic Surgery-prospective and Controlled Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04547608
Enrollment
100
Registered
2020-09-14
Start date
2020-05-01
Completion date
2020-09-04
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Disorder

Keywords

Pain, Propofol, Rocuronium, Temporal summation.

Brief summary

Temporal summation of pain, which is defined as the perception of increasingly greater pain evoked by repetitive painful stimuli, is highly variable between individuals. This study aimed to determine the impact of the timing of rocuronium after induction with propofol on temporal summation of pain in gynecologic laparoscopic surgery.

Interventions

OTHERThe difference of the timing of rocuronium administration after propofol injection

The difference of the timing was rocuronium was administered immediately after propofol injection or when BIS score became below 60 after propofol administration.

Sponsors

Wonkwang University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Attending anesthesiologist knew which anesthetic agents were used. However Outcomes assessor didn't know which anesthetic agents were used.

Intervention model description

One hundred patients, between 18-60 years of age were randomly assigned to one of the two groups; group PRi received immediate injection of rocuronium after propofol administration, and group PRd received rocuronium injection when bispectral index score became below 60 after propofol administration

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Elective gynecologic laparoscopic surgery * American Society of Anesthesiologists' physical status class) I-II

Exclusion criteria

* Menopause (to exclude the hormonal effect on pain) * Patients who had muscular, cardiovascular, hepatic or kidney disorders and patients with a history of medication who would affect muscle relaxants were excluded from this study. * Patients with difficult venous access on forearm, a known allergy to propofol or rocuronium, chronic pain, pregnancy, and those who had received analgesics or sedatives within the previous 24 hours, were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
the grade of rocuronium induced withdrawal movement.during anesthesia inductionwithdrawal movements were graded by the investigator according to the following scale: 1. \- no pain (no response); 2. \- mild pain (movement at wrist only); 3. \- moderate pain (movement involving the arm only with elbow or shoulder); 4. \- severe pain (generalized response or movement in more than one extremity

Secondary

MeasureTime frameDescription
visual analog scale (VAS) for injection painduring anesthesia inductioncheck VAS for pain after propofol administration. visual analog scale with 100 mm for pain after surgery. 0 = no pain, 100 = the worst pain
VAS for painat 1 hour, 24 hours and 48 hourscheck VAS with 100 mm for pain after surgery. 0 = no pain, 100 = the worst pain
Patient controlled analgesia (PCA) Opioid consumptionat 24 and 48 hourscheck the volume of PCA Opioid consumption (ml) (PCA) pump containing fentanyl (800 ug), ketorolac (150 mg), and ramosetron (0.6 mg) in a total volume of 150 mL of saline was set to deliver a basal infusion of 2 mL/h and bolus doses of 0.5 mL, with a 15-min lockout period for postoperative analgesia.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026